Search Results
-
FILTER BY DATEAll Time
-
-
FILTER BY RELEVANCEMost Relevant
-
-
FILTER BY CONTENT TYPEAll Content Types
-
Reviewing "The Myth of The Paperless Office" for the New Yorker in 2002, Malcolm Gladwell argued that if the computer had come first, and paper didn't exist, someone would have had to invent it. Paper, it turns out, is a lot more useful than we typically appreciate.
Patients would be better off if states were able to tailor the benefits that Medicaid covers—targeting resources to sicker people and giving healthy adults cheaper, basic coverage.
Drug makers aren't chasing blockbusters like Lipitor anymore, or uncovering compounds the same way.
Two recent experimental drugs demonstrate that new scientific principles are faster becoming superior medicines, but bad government policies threaten to reverse this trend.
The FDA should be required to disclose its reasons for rejecting a drug, and Congress should reaffirm the provisions of the FDA Modernization Act.
Styrene's recent listing as "reasonably anticipated to be a human carcinogen" means something very different from how it is being framed by advocacy groups and the media—and this knowledge gap threatens to wreck legislative havoc across the country.
Cigarette smoke may not be an equal opportunity carcinogen.
Former Speaker of the House Newt Gingrich points out that when government levies a tax, businesses will not ultimately pay it--consumers will.






